Speeding innovation for industry
Success | Biotechnology
Leti innovation stories
For a cosmetic to be effective, its active ingredient must be sufficiently well-protected to penetrate the skin and interact with cells. Modernist Serum no. 4 is setting a new standard with nanovector encapsulation to protect active ingredients and deliver them to specific cells.
The active ingredient is encapsulated in NeoGouttes Target™, a biodegradable lipid-based nanovector with a hydrophilic membrane that can target specific cells. The product can encapsulate up to 70% of its weight in active ingredients. And, with a diameter of around 100 nm, NeoGouttes Target™ penetrates the skin easily to reach the desired cells.
Leti transferred its nanovector technology to cosmetics science company Capsum in 2010. Capsum encapsulates active ingredients for its customers and manufactures its own line of products. The same nanovector technology is also used to carry drugs to specific organs.
Leti’s nanovectors do more than just protect active ingredients. They can be used to target delivery to specific cells by grafting a biomolecule onto their surface.
Resources and skills
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.